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Sporadic Alzheimer’s disease (AD) is the most prevalent form of age-related dementia.
As such, great effort has been put forth to investigate the etiology, progression,
and underlying mechanisms of the disease. Countless studies have been conducted,
however, the details of this disease remain largely unknown. Rodent models provide
opportunities to investigate certain aspects of AD that cannot be studied in humans.
These animal models vary from study to study and have provided some insight, but no
real advancements in the prevention or treatment of the disease. In this Hypothesis and
Theory paper, we discuss what we perceive as barriers to impactful discovery in rodent
AD research and we offer potential solutions for moving forward. Although no single
model of AD is capable of providing the solution to the growing epidemic of the disease,
we encourage a comprehensive approach that acknowledges the complex etiology of
AD with the goal of enhancing the bidirectional translatability from bench to bedside and
vice versa.
Keywords: Alzheimer’s disease, rodent model, aging, hippocampus, memory, cognition, neurodegeneration,
dementia
Introduction
Alzheimer’s disease (AD) is an insidious, devastating, aging-related disease that has debilitating
effects on cognition. AD is truly a plight of aging, with ∼10 and ∼40% of people over the age of
65 and 85, respectively, being affected (Alz.org, 2014; Mormino, 2014). It is estimated that there
are currently five million cases of AD in the United States and ∼20–30 million cases world-wide
(Lecanu and Papadopoulos, 2013; Prince et al., 2013; Iqbal et al., 2014). The number of AD cases
is expected to double every 20 years, and triple by 2050 (Prince et al., 2013; Iqbal et al., 2014). An
early-onset, familial form of Alzheimer’s disease (FAD), which has been linked to mutations in the
PS1 and PS2 genes has been identified. However, by far the most common form of Alzheimer’s
disease is the sporadic form (SAD), which accounts for ∼85% of cases. Apolipoprotein ε4 allele
(ApoE4), which is involved in amyloid beta (Aβ) trafficking and neural plasticity, is the strongest
genetic precursor for SAD (Corder et al., 1993; Kalaria, 2000; Mahley and Rall, 2000; Kim et al.,
2009; Fjell et al., 2014; for review see, Schellenberg and Montine, 2012). People carrying ApoE4
are two to three more times likely to develop SAD (Kalaria, 2000; for review see Kim et al., 2009).
However, the presence of this allele is not causative. The current paper will focus mainly on SAD
due to its much higher prevalence than FAD.
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In addition to the toll that SAD takes on those aﬄicted and
their families, this growing epidemic affects society as a whole.
In people over the age of 60, it accounts for more disability years
than cancer, stroke, cardiovascular diseases, and musculoskeletal
disorders (Ferri et al., 2005). AD is a very costly disease, in
2014 it was estimated that the United States spent 214 billion
dollars caring for AD patients, with the bulk of that money
being spent on Medicare and Medicaid (Alz.org, 2014). Similar
to the SAD prevalence statistics, the costs associated with this
disease are expected to grow to 1.2 trillion dollars by 2050 in
the United States (Alz.org, 2014). Developing better ways to
diagnose, prevent, and treat SAD is of paramount importance
for patients, their families, and society in general. Currently,
pharmacological treatments for SAD are limited and their
effects on memory are unimpressive (Mesulam, 2004), which
is likely due to the complex etiology, heterogeneous pattern
of pathology, and underlying mechanisms that continue to be
elusive (McDonald, 2002).
SAD causes deleterious effects on various types of memory,
such as: memory for personal experiences (episodic memory),
spatial memory, and working memory (Tulving, 1993; Joseph
et al., 2001; Serino et al., 2014). All of these types of memory rely
heavily on intact hippocampus (HPC) and paraHPC function.
Episodic and spatial memory are two of the first cognitive
processes to be compromised, with executive function being
affected in later stages of the disease (Grober et al., 2008; Serino
et al., 2014). Neural degeneration, insoluble fibrous deposits
in the form of amyloid plaques, and neurofibrillary changes
such as Tau hyperphosphorylation are the key pathologies
associated with SAD (Braak and Braak, 1991; Braak et al.,
2011). Alzheimer’s disease pathology progresses slowly and can
take 10 years or more before AD is actually diagnosed (Jack
et al., 2013). Medial temporal lobe areas involved in learning
and memory such as, HPC, entorhinal (EC), and retrosplenial
cortices are especially susceptible to these pathologies (Braak
and Braak, 1991; for reviews see, Fjell et al., 2014; Small, 2014),
as well as the effects of normal aging. In some cases in which
only mild cognitive impairment is present, SAD can only be
accurately diagnosed posthumously through ex-vivo examination
(Snowdon et al., 1997). This suggests that the damage and
degeneration caused by SAD pathology does not always result
in cognitive deficits. Similarly, due to the slow progression
and the heterogeneity of pathology in SAD, the pathology-
behavioral threshold∗ (∗the point at which cognitive deficits can
be detected due to brain pathology) itself is likely subject to
a myriad of cofactors (McDonald, 2002). This threshold can
vary from case to case, in a somewhat unpredictable manner.
In addition to cognitive functioning, other co-morbidities such
as, circadian rhythm dysfunction, depression, aggression, or
psychosis can be associated with AD (Coogan et al., 2013; Lecanu
and Papadopoulos, 2013).
As discussed in our previous work, we argue that the etiology
of SAD is complex, and the pathology associated with SAD,
as well as the behavioral consequences of the pathology are
heterogeneous (McDonald, 2002; McDonald et al., 2010; Craig
et al., 2011). One major issue is how the mechanisms of HPC
dysfunction in SAD might be more diffuse and inconsistent
across the entire system, which makes it difficult to detect
behaviorally. This has been especially true in studies that use
rodents. The gold standard behavioral tasks that have been
employed with great success in the past to elucidate HPC-
dependent behaviors in intact and HPC damaged rodents seem
to fall short when attempting to reveal and quantify cognitive
deficits in rodent models of SAD. Even in cases where there is
considerable pathology and degeneration within the system, this
does not always breach the behavioral threshold (Amtul et al.,
2014a,b). We attribute this to the sparse, distributed nature of
memory representations in HPC systems and the insensitivity
of many of the classic HPC-dependent memory tasks to detect
mild deficits in learning, memory and cognition. Additionally, it
is our position that in some models, the induced or inbred SAD-
like pathologies are often excessive, unifactorial, have unwanted
side effects, and are not bidirectionally translatable. That is,
as will be discussed below, not only are there difficulties in
translation from bench to bedside, but from clinical cases to
primary research as well. This issue, in combination with the
difficulty in quantifying SAD-like behavioral impairments in
rodents, represents a considerable impediment to advancements
in the field of AD research. Although it may be tempting to
seek out a universal rodent model of SAD, we maintain that the
search for a single AD behavioral phenotype in rodents may be
misguided due to the complexity of the disease.
The main goal of this paper is to address what we see
as disconnect between the clinical reality of SAD and the
primary rodent research in this field. Our hypothesis is that this
disconnect is due to a reliance on inappropriate animal models
and insensitive behavioral tasks. First, we will briefly discuss
the evidence for the complexity and distributed nature of the
HPC-based memory system and the behavioral tasks employed
to identify the behavioral correlates of HPC dysfunction. Our
focus on the HPC is based on our strongly supported assumption
that the HPC is a major target of brain dysfunction in SAD.
Second, we will evaluate some of the current rodent models
of AD and identify what we perceive as barriers to progress
in primary AD research. Lastly, we will synthesize these points
of view and discuss them within the context of our cofactor
theory of SAD. Our theory is that the cofactor model and
more sensitive behavioral tasks will better represent aspects of
human SAD that are typically absent in animal models, such
as mechanism heterogeneity, AD sex differences, and nature
of brain pathology. The issues raised in our paper speak to
the topic of this special issue on how to progress in the fields
of neuroprotection and rehabilitation by presenting important
confounds associated with current rodent models of SAD and
offering suggestions on how to move forward. Impactful progress
in the fields of neuroprotection and rehabilitation, in our view,
requires development of valid rodentmodels and behavioral tools
for SAD that are specific for this devastating brain disease.
The HPC and Memory
In this section we will provide arguments and support for a
simple idea that we feel has significant implications for research
directed at developing rodent models of SAD. The idea is based
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on the fact that many of the well-accepted behavioral assays
for hippocampal function were developed using techniques that
render the HPC almost completely dysfunctional (complete
lesions or inactivations). This is fundamental work but we believe
that valid rodent models of SAD will actually produce partial
or heterogeneous dysfunction of the HPC. This means that
although significant portions of the HPC may be dysfunctional
in a specific rodent model of SAD, standard assays of HPC
function might not detect these changes leading the researcher
to erroneously conclude that the model was inadequate. Below
we will review key anatomical and functional organization of the
HPC formation that makes it more difficult to detect functional
impairments than other systems that are organized in a different
way.
HPC Anatomical Organization
Justifiably, the HPC and its associated regions are a major
focus of study with respect to any disorder that affects learning
and memory, specifically diseases of aging like SAD. An
extensive body of theoretical and empirical work has amassed
and provides strong evidence for the crucial role of HPC
and paraHPC areas in learning and memory. Classically, the
HPC proper was considered to be primarily a straight-forward
circuit with unidirectional flow of information. Although
the flow of information in HPC is largely unidirectional,
HPC neuroanatomy lends itself to both serial and parallel
processing with extensive reciprocal extrinsic connectivity,
and intrinsic connectivity, which constitutes multiple parallel
closed loops (Amaral and Lavenex, 2007). The HPC receives
large amounts of input from all neocortical sensory areas
via the EC and in turn, HPC efferents are sent back
to the neocortex through the subiculum and EC (Amaral
and Witter, 1989; Amaral and Lavenex, 2007). The HPC
system is thought to form and maintain distinct multisensory
associations, which are hypothesized to support unique, cohesive
episodic memory representations (Sutherland and Rudy, 1989;
Gruber and McDonald, 2012). These representations allow the
organism to navigate through space effectively, temporally order
events, and discriminate highly ambiguous situations using
pattern separation/completion mechanisms (Morris et al., 1982;
Sutherland et al., 1983; Leutgeb et al., 2004; Mankin et al., 2012;
Hunsaker and Kesner, 2013; Serino et al., 2014).
The HPC and paraHPC regions generate and support
allocentric (reliance on distal cues) and egocentric
representations of the world (reliance on ones’ position),
which then can be integrated to form conjunctive units (Wilber
et al., 2014). These representations can then guide future
behavior, and are hypothesized to be one of the key substrates
of memory. For example, spatial navigation can be mediated
by distal allocentric, or egocentric idiothetic (self-movement
generated) cues (O’Keefe and Nadel, 1978; Etienne et al., 1988;
Maaswinkel et al., 1999; Martin and Wallace, 2007). Remarkably,
rodents can use idiothetic cues in the absence of distal cues to
navigate back to their starting location after foraging for food
(Etienne et al., 1988; Maaswinkel et al., 1999; Martin andWallace,
2007). This phenomenon is referred to as path integration and
is dependent on the hippocampus (Maaswinkel et al., 1999) and
the septohippocampal cholinergic system (Martin and Wallace,
2007).
The HPC system is able to create these allocentric and
egocentric representations by encoding and processing signals
from place cells, head-direction cells, and grid cells (Derdikman
and Moser, 2010). In the rat, place cells generate an internal
map of the environment, thereby providing an allocentric
representation of locations within said environment (O’Keefe
and Dostrovsky, 1971; McNaughton et al., 1983; O’Keefe and
Speakman, 1987). These representations are stable over time
and within each environment, but have the capability of rate
and global remapping (Muller and Kubie, 1987; Leutgeb et al.,
2005). Head direction cells are neurons that show high rates
of firing when the animal’s head points in a specific direction.
These neuronal firing rates return to baseline when the subject’s
head turns about 45◦ from this preferred direction. Unlike place
cells, these neurons are orientation specific, location invariant,
and appear strongly dependent on the vestibular system. Head-
direction cells are thought to contribute egocentric information
about the direction of visual attention (Taube, 1998). Neurons
classified as grid cells fire action potentials in small clusters
with the clusters forming the vertices of a grid of equilateral
triangles. Grid cells are found in the medial entorhinal cortex
(MEC) and are posited to support the process of updating the
rat’s position within a spatial map via self-motion information,
which is sometimes called path integration (Moser et al., 2008).
In humans, and perhaps rodents, another paraHPC region,
the retrosplenial cortex is thought to transform and integrate
allocentric and egocentric representations generated in HPC
regions (Maguire, 2001; Vann et al., 2009). Together, this network
constructs and represents space in the brain. This multisensory
construct can then be used to guide behavior and recall events
associated with these places.
Another interesting feature of the HPC system is how it can
represent seemingly endless amounts of information without
experiencing catastrophic interference (McClelland et al., 1995).
Evidence from computational and in vivo studies strongly
suggests that memory representations are sparsely coded over
distributed networks of neurons (Moser and Moser, 1998;
Leutgeb et al., 2007; Wixted et al., 2014). This is hypothesized
to greatly increase the associative capacity of HPC networks and
lower the probability of interference between representations.
The complex, sparse, and distributed nature of memory
representations in the HPC system becomes a considerable
obstacle to overcome when attempting to study moderate, diffuse
damage, characteristic of early to mid-stage SAD. What we
refer to as the “gold standard” HPC-dependent behavioral tasks
used to elucidate learning and memory deficits in rodents
might be insensitive to this kind of incomplete hippocampal
damage. Classic versions of the 8-arm radial arm maze (RAM;
Olton et al., 1979), Morris water task (MWT; Morris et al.,
1982; Sutherland et al., 1983), path integration task (Maaswinkel
et al., 1999), and contextual fear conditioning (Sutherland
and McDonald, 1990), have been useful in identifying HPC
deficits on a behavioral level in the past. These behavioral tasks
have the benefits of being well described and methodologically
uncomplicated. However, as the field of HPC learning and
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memory research evolves, it is becoming clear that these “gold
standard” tasks have limitations. These limitations become
apparent when attempting to investigate HPC system damage
or degeneration that is incomplete, diffuse, or heterogeneous.
For example, in the hidden platform MWT, Moser et al.
(1995) demonstrated that rats are able to learn and perform
the task with ∼74% of their HPC lesioned. Due to the
extensive lesions, the authors referred to the small amount of
dorsal HPC (dHPC) tissue as a “minislab.” Similarly, in single
exposure contextual fear conditioning, rats given incomplete
HPC damage after acquisition can display freezing behavior (Kim
and Fanselow, 1992; Lehmann et al., 2007). These studies suggest
that animals can display intact memory in these tasks despite
substantial damage to the HPC. Again, we believe this can be
attributed to the sparse and distributed nature of HPC memory
representations. Additionally, altered experimental procedures
such as repeated exposure, distributed training, or a within-
subjects design involving multiple retention sessions instead
of single exposure in contextual conditioning, can confound
the HPC-dependent nature of the task (Lehmann et al., 2009).
Engaging extrahippocampal memory systems renders the task
ineffective for quantifying HPC-based memory impairments.
Along this line, in a section below, anterograde and retrograde
memory impairments will be discussed in the context of multiple
memory systems.
Multiple Levels of Functional Organization of the
HPC
Anatomical, pharmacological, and electrophysiological studies
seem to suggest that the organization of the hippocampal
formation follows certain topographical principles that
could provide the substrate for memory-based behavioral
subsystems. These include, but are probably not limited to,
functional specificity at the intrahippocampal subfields, along
the septotemporal axis, and various levels of anatomical
organization between different portions of the EC and HPC.
Functional Specificity at the HPC Subfield Level of
Description: Dentate Gyrus, CA3, and CA1
One obvious organizing principle of the functions of the HPC
is the different subfields found within the structure. Briefly,
extensive projections from the EC terminate on granule cells
in the dentate gyrus. The granule cells in this subfield, in turn,
project to the CA3 region via the mossy fiber system and synapse
on pyramidal neurons there. CA3 pyramidal cells project to the
CA1 region via the Schaffer collateral fiber system (Amaral and
Witter, 1989).
There is evidence suggesting that each of these regions makes
a specific contribution to hippocampal processing and functions.
For example, it has been shown that the dentate gyrus and CA1
regions make differential contributions to spatial learning with
dysfunction to the former impairing performance, while CA1
dysfunction enhances performance (Okada et al., 2003). Further,
the dentate gyrus has been implicated in pattern separation,
although this remains controversial (Spanswick and Sutherland,
2010). Others have recently shown that both the CA1 and CA3
contribute to the acquisition of context-dependent extinction
but that CA1 is specifically required for contextual memory
retrieval (Ji and Maren, 2008). Electrophysiological and lesion
data suggests that the CA3 region is involved in rapid one-
trial place learning, answering an unexpected question, pattern
completion, and some forms of sequence learning (Zhou et al.,
2012; Kesner and Rolls, 2015).
The implications of this regional specificity of function in
the HPC are that SAD may preferentially compromise one or
more of these systems and not the other, or damage all of these
systems in one extent of the HPC but leave these systems intact
in another part. In the former case, this may lead to more
specific and subtle impairments that would require specific and
sensitive assays for those subregional functions. In the latter case,
memory impairments would be hard to detect unless one knew a
priori which part was compromised and there was a behavioral
assay available that was sensitive to the functions of that
region.
Functional Circuits via Interactions between Portions
of EC and HPC: Medial and Lateral EC and
Longitudinal Strips
There are other ways to conceptualize information processing in
HPC and associated intrinsic functional circuitry. For example,
the major input to the HPC from all major cortical areas arises
from the EC. Based on anatomical criteria, the EC has been
subdivided into medial and lateral subregions (Witter et al.,
2000). These subregions project into the HPC via different
fiber tracts called the medial and lateral perforant path. With
segregated input paths, different cortical inputs, and termination
patterns in the different subregions of HPC it is reasonable
to believe that these regions provide different information
to the HPC and subserve different memory-based behavioral
functions. Briefly, based on anatomical, electrophysiological,
and behavioral evidence it has been argued that the MEC
is preferentially involved in spatial navigation supported by
idiothetic cues (self-motion) and the lateral EC processes local
cues, cue configurations, and cue locations (Ferbinteanu et al.,
1999; Knierim et al., 2014).
There has been a different way of conceptualizing HPC
information processing presented based on other organizing
anatomical principals of the HPC. For example, there are other
interesting topographical relationships between the EC and
HPC that have led us to alternative ways of conceptualizing
information processing and potential functional subcircuits in
the HPC. Briefly, perpendicular to the traditional medial/lateral
EC division there is a second system of parallel circuits
which separates the dorsal and ventral HPC and we have
argued that this organization is the substrate for memory-
based behavioral subsystems. The current stage of the model
indicates at least two hypothetical memory-based behavioral
subsystems within the EC-hippocampal formation. The
DORSAL HIPPOCAMPAL CIRCUIT includes the lateral
entorhinal cortex (LEC) strip, lateral nucleus accumbens, and the
anterior prelimbic cortex. The VENTRAL HIPPOCAMPAL
CIRCUIT includes the MEC strip, the medial nucleus
accumbens, the basolateral amygdala, and the posterior prelimbic
cortex.
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Behavioral Evidence for Functional Circuits in Dorsal
and Ventral HPC
Our laboratory has collected a body of evidence to suggest that
these different subsystems have different effects on memory-
based behaviors.
Conditioned place preference (CPP)
The conditioned place preference task is an appetitive classical
conditioning paradigm that uses distal spatial cues, like
those used in place navigation tasks, as the conditioned
stimuli. We showed that acquisition of this task requires a
synergistic interaction between the amygdala-and hippocampal-
based learning and memory systems (McDonald and White,
1995b; Ferbinteanu and McDonald, 2001) with the HPC
providing complex spatial information and the amygdala
providing access to reward information. Assessment of the
functional significance of the topographical organization of the
EC showed that: (1) rats with dorsal HPC lesions are impaired
at acquisition of the same task suggesting that the dorsal
hippocampal circuit is the crucial site for acquisition of this
task (Ferbinteanu and McDonald, 2001); (2) rats with ventral
hippocampal lesions or fornix lesions show enhanced acquisition
on the CPP task suggesting that the ventral hippocampal
circuit actively inhibits the amygdala-based learning and
memory system (McDonald and White, 1995a; Ferbinteanu and
McDonald, 2001).
Water task
The water maze procedure we use is a variant of the MWT
and is a cue/place task (McDonald and White, 1994). The task
consists of alternation of visible and invisible platform training.
This procedure has various advantages over the traditional
invisible platform water task (MWT). Using this task we have
demonstrated that although the dorsal pole of the HPC is more
efficient than the ventral pole in supporting place navigation,
the dissociation is not absolute (Ferbinteanu and McDonald,
2000, 2003). This interpretation differs from that of Moser and
colleagues (Moser et al., 1993; Moser and Moser, 1998). We have
also reported that MEC input to the HPC but not LEC input is
critical for efficient place learning in the water task (Ferbinteanu
et al., 1999).
Discriminative fear conditioning to context
We have developed a powerful set of procedures for studying fear
conditioning to context (Antoniadis and McDonald, 1999, 2000,
2001). Recently we have shown that both the amygdala and HPC
are learning and memory systems that differentially participate
in fear conditioning to context. Using this task we have
demonstrated that active comparison (active place preference in
which the animal is free to move back and forth between the
paired and unpaired chamber via a connecting tunnel on the test
day) of multiple cues with different emotional valence requires
both dorsal and ventral HPC. Conversely, discriminative freezing
which does not require active comparisons of cues was unaffected
by either lesion (Ferbinteanu and McDonald, 2001). Complete
neurotoxic lesions of the HPC disrupt both discriminative
freezing and preference suggesting that these learning and
memory functions require integration along the septo-temporal
axis of the HPC. The behavioral evidence reviewed above
provides evidence for the proposed memory subsystems in the
HPC and extends our understanding of complex interactions
between these HPC-based memory subsystems and other parts
of the brain.
Demonstrations of Differential Functional Effects of
Anterograde vs. Retrograde HPC Lesions
The asymmetry of anterograde and retrograde lesion effects
on HPC-dependent behaviors provides another experimental
consideration when employing classic HPC memory tasks
to investigate behavioral impairments. In contextual fear
conditioning, rats that receive HPC lesions prior to the single
shock-context pairing display intact memory on retention tests
(Maren et al., 1997; Wiltgen et al., 2006), even when HPC
damage is extensive ∼80% (Sparks, 2011). This could be due to
the residual hippocampal tissue being capable of acquiring the
representations required to learn the shock-context association.
An alternative explanation, especially cases of severe or complete
damage, is that some non-HPC memory system is capable of
acquiring and supporting contextual fear memory in the absence
of the HPC. This idea is supported by multiple memory systems
theory (White and McDonald, 2002) and demonstrations of its
proposed principals (McDonald andWhite, 1994). As mentioned
above, the Moser group found that in MWT, rats with ∼74%
damage to the HPC could learn the location of the hidden
platform. However, other studies have shown deficits in the
anterograde direction with incomplete HPC lesions in MWT
(Sutherland et al., 1983; Sutherland and Rudy, 1988; McDonald
andWhite, 1994; Ferbinteanu et al., 1999). Although not straight-
forward, it has been proposed that retrograde effects are more
easily elicited than anterograde effects in HPC-dependent tasks
(Morris, 2007). The somewhat elusive nature of retrograde
impairments on HPC-dependent tasks in animals that have
incomplete damage might be a function of the aforementioned
distributed nature of the memory representations. Intact pattern
separation/completion mechanisms are likely responsible for
this in contextual fear conditioning, and could require less
residual tissue to function adequately. Behavioral compensation
or a switch of strategy could be responsible for the same
anterograde/retrograde phenomenon in MWT. Another likely
and perhaps complimentary explanation, is that the behavioral
tasks employed might not require the animal to use effortful
memory retrieval and the emotional salience of cues within the
task (appetitive or aversive), or the task itself, provides additional
stability to memories, which could serve to “unburden” more
complex functions of the HPC (Gruber and McDonald, 2012).
Summary
Acknowledging the complexity of HPC and paraHPC
contributions to learning, memory, and cognition, as well
as the interaction of these areas with others that support aspects
of mnemonic functions may provide a key to improving the
characterization of complex SAD pathology and associated
behavioral correlates in rodent models of the disease. Careful
consideration of all the experimental intricacies surrounding
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the visualization of HPC damage, pathology, and representative
behaviors must be appreciated and taken into account when
designing studies involving rodent models of SAD.
Alzheimer’s Disease: Current Approaches
The etiology of AD is very complicated. This is demonstrated
by the fact that most individuals carrying ApoE4, and a subset
of those with other biomarkers of AD never develop AD. For
example, Schneider et al. (2007) observed that 24.2% of the brains
from people in a retirement home with AD neuropathology were
asymptomatic. This is likely because markers of AD, such as,
amyloid plaques are not always positively correlated with degree
of cognitive impairment (Giannakopoulos et al., 2003). Similarly,
total HPC volume is not the best marker for AD because
accelerated atrophy is a normal part of aging (Driscoll et al.,
2009). Furthermore, there are other cognitive disorders, such as
semantic dementia that have similar amounts of hippocampal
atrophy (La Joie et al., 2013 for review see, Maruszak and Thuret,
2014).
Joseph et al. (2001) adopted a multi mechanistic approach
by theorizing that membrane alterations, inflammation, and
oxidative stress contribute to neurodegeneration and ultimately
cognitive impairments. Along this line, it is currently believed
that AD has a very complex etiology consisting of many risk
factors (Joseph et al., 2001; McDonald et al., 2010; Craig et al.,
2011). As highlighted by the statistics presented in the beginning
of this section, by far the strongest predictor of developing AD is
age (Kawas et al., 2000; Joseph et al., 2001; Fjell et al., 2014).
We have proposed a cofactor approach to explain the complex
etiology of SAD (McDonald, 2002; McDonald et al., 2010; Craig
et al., 2011).Within this model, risk factors, which predominately
affect brain areas that mediate learning and memory, have an
additive effect, such that hippocampal pathology worsens with
more risk factors (see Figure 1). There are active factors, such
as stroke or seizure, which cause neuronal death, and passive
factors, such as cholinergic depletions or Aβ, which make the
brain more susceptible to the damaging factors (for review see,
McDonald, 2002). The idea is that there would be very little
or no brain pathology and cognitive impairment when one
of these factors is present, but several of these factors would
create more severe brain pathology and cognitive impairments
(see Figure 1). The cofactor model suggests that effects of AD
treatments are heterogeneous despite patients having very similar
symptomology because it is likely that across patients different
mechanisms are elicited by the specific combination of risk
factors present (McDonald et al., 2010).
Generally, risk factors are believed to affect hippocampal
functioning primarily via neurodegeneration or altering
plasticity/signal transduction in the HPC (for reviews see,
Joseph et al., 2001; McDonald et al., 2010; Fjell et al., 2014). For
example, functions and/or molecules necessary for hippocampal
dependent memory, such as neurogenesis, acetylcholine, and
brain derived neurotrophic factor are all altered in AD patients
(Honea et al., 2013; Lazarov and Marr, 2013; Maruszak et al.,
2013; for reviews see, Craig et al., 2011; Maruszak and Thuret,
2014). Acetylcholine particularly has been linked to AD, as AD
patients have a loss of cholinergic neurons in the basal forebrain
(Davies and Maloney, 1976; Mesulam, 2004; Craig et al.,
2011). Cholinergic depletion of the medial septum dramatically
decreases the amount of acetylcholine in the hippocampus
and in animal models can impair memory in certain tasks,
such as those that assess spatial working memory or path
integration (Lehmann et al., 2003; Martin and Wallace, 2007;
Craig et al., 2011), but typically not declarative spatial memory
(Berger-Sweeney et al., 1994; Baxter et al., 1996). Although it is
unclear if cholinergic depletion precipitates AD or is a symptom,
interestingly, acetylcholine agonists are some the most common
and effective drugs used to ameliorate memory impairments in
AD patients (Craig et al., 2011). However, it should be noted
that the beneficial effects of acetylcholine agonists are small and
often not long-lasting (Craig et al., 2011). Our theory is that
cholinergic depletion increases the likelihood of AD by making
the hippocampus more prone to damage or dysfunction when
presented with other risk factors (Craig et al., 2011).
Animal Models of Alzheimer’s Disease
As a result of the complex and largely unknown etiology of AD,
animal models are particularly useful and ultimately necessary
to study possible causes and treatments of this disease (Sodhi
et al., 2014). Not surprisingly, due to the contention surrounding
the etiology of AD, there is no standard animal model of AD
(Joseph et al., 2001; Lecanu and Papadopoulos, 2013; Iqbal et al.,
2014; Sodhi et al., 2014). Animal models attempt to create AD
like brains and cognition by changing the genome, or by adding
chemicals to the brain (Sodhi et al., 2014). We will discuss the
various strengths and weaknesses of some of the animal models
of AD.
Transgenic Animal Models of AD
Upon the discovery that mutations in specific genes cause
familial AD, transgenic mice with similar genomes were created.
Transgenic mouse and rat models of AD are currently the
most popular animal model of AD (Lecanu and Papadopoulos,
2013; Iqbal et al., 2014; Sodhi et al., 2014). Most of the
transgenicmodels involve genetic manipulations that lead to over
expression of Aβ and/or promote the formation of neurofibrillary
tangles (for reviews see, Braidy et al., 2012; Sodhi et al., 2014).
While there are many transgenic models, typically those that pair
several mutations have been the most successful at mimicking
AD pathology (Braidy et al., 2012; Lecanu and Papadopoulos,
2013; Sodhi et al., 2014). Some examples include models, in
which amyloid precursor protein (APP) mutations have been
paired with PSEN1 (APP/PS1), and, or tau mutations (APP/tau;
APP/PS1/tau) (Borchelt et al., 1997; Lewis et al., 2001; Oddo
et al., 2003). Depending on the specific mutations used, these
models elicit memory impairments that are thought to be due
to increased Aβ and/or neurofibrillary tangles (for reviews see,
Braidy et al., 2012; Sodhi et al., 2014).
Evaluation of transgenic models
The primary strength of transgenic animal models is that they
closely resemble FAD, in terms of the mechanism mediating AD
pathology. The use of transgenic models has been crucial, as they
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FIGURE 1 | Simplified schematic of the cofactor theory of SAD
illustrating the interaction between risk factors, and their impact on
HPC pathology and cognition. Although these interactions are complex
and the pathology is often heterogenous, the cofactor theory can be utilized
to model different stages of Human SAD. Most importantly, the theory
presents numerous, testable ideas that have yet to be assessed at all levels
of analysis including: mechanisms of HPC dysfunction in preclinical animal
models, clinical research assessing the potential for subgroups of individuals
with different combinations of cofactors, and assessment of different
preventative measures and treatment options.
have elucidated a lot of the molecular mechanisms/biomarkers
that contribute to AD pathology (Balducci and Forloni, 2011;
Braidy et al., 2012; Lecanu and Papadopoulos, 2013). That
being said, transgenic animal models of AD possess weaknesses,
some of which we feel are hard to overlook. First, these
models only represent FAD, which as mentioned above, only
accounts for ∼5% or less of all AD cases (Balducci and
Forloni, 2011; Lecanu and Papadopoulos, 2013; Iqbal et al.,
2014).
Second, many of these models produce pathologies that might
not be representative of human AD pathology. Many transgenic
models overexpress APP and thus these models are producing
phenotypes that are not just a result of increased Aβ loads
(Joseph et al., 2001; Saito et al., 2014). For example, in some
transgenic models amyloid pathology is created by the unrealistic
overexpression of APP (5–10 fold) and then subsequent Aβ
levels (5–12 fold) (for review see, (Balducci and Forloni, 2011)).
These models are similar to very severe cases of dementia,
which report up to an 11.9 fold increase of Aβx−42 in the
temporal lobe (Näslund et al., 2000). However, this varies greatly
depending on the brain region studied, as there was only a 4.6
fold increase of Aβx−42 in the frontal cortex of the same patients
(Näslund et al., 2000). Similarly, studies using patients with early
dementia or a sample of sporadic AD patients, report as little
as ∼1.5 fold increase in Aβ depending on the Aβ fragment
and brain region (Näslund et al., 2000; Klunk et al., 2004; Li
et al., 2004). Additionally, in many transgenic models oligomeric
Aβ expression is also very different from that found in human
AD patients (for review see, Balducci and Forloni, 2011). Thus,
Balducci and Forloni (2011) stated that in contrast to humans,
the Aβ pathology created by transgenic models is excessive and is
more similar to the rare FAD.
In addition to unrealistic Aβ overexpression, many of the
transgenic models that use tau mutations produce unrealistic
tau pathology. First, tau mutations have never been found in
AD patients (Tackenberg and Brandt, 2009; Umeda et al., 2014).
Second, some of the FTDP-17 tau mutation models produce tau
that is more toxic than wild type tau and the mechanisms for how
Aβ interacts with tau is even different from wild type tau in these
mutants (Tackenberg and Brandt, 2009). Furthermore, some of
these models produce neurofibrillary tangles in the absence of
Aβ, which contradicts the classic theory that Aβ precipitates
abnormal tau pathology (Hardy and Selkoe, 2002; Frank et al.,
2008; Umeda et al., 2014).
There are other less severe weaknesses of transgenic models.
For example, these transgenic models typically do not cause
very much neurodegeneration, which some consider to be
the hallmark of AD pathology (Lecanu and Papadopoulos,
2013). Another flaw is the timing of the presentation of brain
pathology and behavioral impairments. For example, typically
these animals possess the genetic mutations from birth, so
there is not always much disease progression (Sodhi et al.,
2014). However, behavioral impairments in transgenic mice
models are not always seen until the animals have aged, which
makes it hard to determine exactly how the induced AD
pathology is affecting the brain and behavior mechanistically
because aging also affects many other processes (Joseph et al.,
2001).
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Additionally, for several reasons, it is very hard to compare
transgenic models of AD. First, many different mice strains or
hybrid strains are used for transgenic mouse models (Joseph
et al., 2001). This strain heterogeneity makes it hard to compare
transgenic models, as there are strain specific differences in the
performance of behavioral tasks (Joseph et al., 2001). Hybrid
mouse strains can also have vision problems that confound
any results obtained from behavioral testing (Borchelt, 1998;
for reviews see, Joseph et al., 2001; Brown, 2007). Second,
aspects of pathology, such as the location of Aβ plaques and
neurofibrillary tangles, vary depending on the promoter region
used to incorporate the transgene into the animal’s genome
(Braidy et al., 2012; Lecanu and Papadopoulos, 2013). Therefore,
different models using similar genetic mutations can produce
very different brain pathologies and cognitive deficits.
Finally, the overwhelming majority of transgenic models use
mice (Sodhi et al., 2014). This can be problematic because in
contrast to the rat, less is known about the effect of lesions
and pharmaceuticals on mouse behavior (Young et al., 2013).
Furthermore, behavior in the “gold standard” hippocampal
dependent memory tasks is not always analogous between
species, as mice perform worse than rats in the MWT (Whishaw
and Tomie, 1996).
Cofactor Models
As discussed by Sodhi et al. (2014) many chemicals, such as
exogenous Aβ, neurotoxins that target specific cell types, heavy
metals, and sodium azide can be given to rodents to model
AD. 192 IgG-Saporin is a commonly used neurotoxin that is
favored by our and other labs because of its selective specificity
for cholinergic neurons. We use 192 IgG-Saporin to reduce ACh
in the hippocampus (>60%) by abolishing cholinergic neurons
in the medial septum (Craig et al., 2011). Many neurotoxins
produce cognitive impairments and aspects of AD pathology (for
review see, Sodhi et al., 2014). However, these models typically
only produce partial AD pathology because primarily one factor
is used. For several reasons, this is not likely representative of true
AD pathology. First, multiple factors are involved, and second, as
mentioned many of these studies use unrealistic factor amounts
(Joseph et al., 2001). While, this approach is beneficial because it
helps verify whether or not a factor is a potential mechanism, this
approach does not create realistic AD pathology.
Our lab and other labs utilize a cofactor animal model that
involves the presentation of various combinations of risk factors
to rodents. We use a sub-threshold dosing strategy, so the idea
is that one risk factor will have a minimal effect on brain
pathology and cognition, however, multiple factors presented
concomitantly will exacerbate brain pathology and produce
cognitive impairments. To our knowledge, Dornan et al. (1993)
provided the first evidence of the cofactor effect by only observing
impaired MWT acquisition when both Aβ25−35 and ibotenic
acid were injected into the HPC and not when each factor was
presented in isolation.
We have presented various combinations of risk factors to rats
(for review see, Craig et al., 2011). As indicated above, age is the
strongest risk factor for AD. However, it is difficult to determine
why aging induces AD as many brain pathologies occur during
aging (Joseph et al., 2001; Fjell et al., 2014). Thus, we try to
determine which of the age-induced pathologies contribute to
AD by creating these pathologies in young adult male Long Evans
rats.
We have demonstrated that the following pairings of active
and passive factors have affected hippocampal dependent
behavior and/or pathology: cholinergic depletions + stroke
(Craig et al., 2009a); cholinergic depletions + kainic acid
seizures (Craig et al., 2008b); aging + hippocampal mini-
strokes (Driscoll et al., 2008); stress+ hippocampal mini-strokes
(McDonald et al., 2008). Recently, as predicted by our theory,
for the first time, we observed that the pairing of two active
factors—acute circadian rhythm disruption and hippocampal
mini-strokes—reduced total hippocampal volume and increased
neurodegeneration in the HPC (see Figure 2). This finding is
notable because as will be discussed below factor combinations
do not always exacerbate brain pathology, even in some instances
when they elicit behavioral impairments.
Interestingly, some active and passive factor pairings have
caused little or no behavioral impairments: circadian rhythm
disruption + cholinergic depletions (Craig et al., 2009b); Aβ +
striatal mini-strokes (Amtul et al., 2014a,b; Keeley et al.,
2015). Similarly, the pairing of circadian rhythm disruption +
cholinergic depletions did not cause hippocampal pathology
(Craig et al., 2009b). Surprisingly, we have also observed
varying degrees of behavioral impairments and hippocampal
pathology when two passive factors were paired together: stress+
cholinergic depletions (Craig et al., 2008a); stress + Aβ (Deibel
et al., unpublished); cholinergic depletions + Aβ (Deibel et al.,
unpublished). These data sets suggest that the cofactor theory
is not a basic two-hit theory, nor are the active and passive
requirements always met. For example, the shift/stroke data
presented above, particularly demonstrates that the co-factor
theory is not just a two-hit theory and depends on the specific
factors used, as circadian rhythm disruption had no effect on
pathology and behavior when paired with cholinergic depletions
(Craig et al., 2009b). With this in mind, recently we have
argued that some of these factors have both passive and active
components. For example, the finding that stress exacerbates
pathology when paired with a passive factor (cholinergic
depletions; Aβ) or active factor (mini-stroke) suggests that it
could have both active and passive characteristics (Deibel et al.,
unpublished; McDonald et al., 2008). Similarly, Aβ likely has
both passive and active characteristics, as some pathology is more
severe when Aβ is paired with a passive (stress) or active factor
(mini-stroke) (Amtul et al., 2014a,b; Deibel et al., unpublished).
In summary, as discussed in Craig et al. (2011), several
patterns of results emerge from our data. Some factor
combinations can elicit significant hippocampal neuronal
cell death and hippocampal dependent learning impairments
(shift/stroke data presented above; Driscoll et al., 2008;
McDonald et al., 2008). Conversely, some factor combinations
can result in no hippocampal pathology, but behavioral
impairments in hippocampal dependent learning tasks (Craig
et al., 2008a,b, 2009a,b; Keeley et al., 2015; Deibel et al.,
unpublished). Other factor combinations can cause hippocampal
or striatal pathology, but no or very minimal behavioral
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FIGURE 2 | Hippocampal volume and fluoro Jade staining in rats
with mini-hippocampal strokes and acute circadian rhythm
disruption. Rats received: incisions and sutures (sham); 6 days of
photoperiod shifting (shift; Devan et al., 2001; Zelinski et al., 2014);
0.5µl of 6 pmol endothelin-1 (ET-1) was injected into the
hippocampus via two sites bilaterally (stroke; McDonald et al., 2008);
6 days of photoperiod shifting and then ET-1 infusions (shift/stroke).
Twenty-two days after these manipulations, the rats were perfused
transcardially with PBS and 4% buffered paraformaldehyde. Sliced
sections (40µm) were either stained with Cresyl violet for volume
analysis, or 0.0004% Fluorojade-B (FJ) for identification of damaged
neurons (McDonald et al., 2008). Whole hippocampal volumes were
measured using the Cavalieri method via StereoInvestigator
(Microbrightfield, Williston, VT). Every sixth section was counted with
an average of 14 sections assessed for each animal. If sections were
missing from a series (on average 1 section per animal), stereo
investigators correction for missing sections was used. For the FJ
analyses, ImageJ was used to create a threshold that selected the
FJ fluorescent signal in the whole hippocampus and then the area of
this selected region was quantified in each of three representative
sections per animal (−2.56, −3.8, and −4.8mm from bregma
respectively). (A) Representative images used for the volume analyses:
sham (n = 8); shift (n = 9); stroke (n = 8); shift/stroke (n = 6). (B)
Representative images used for the FJ analyses: sham (n = 5); shift
(n = 7); stroke (n = 8); shift/stroke (n = 6). (C) A One-Way ANOVA
indicated that hippocampal volume differed among the groups
[F(3, 27) = 6.058, p = 0.003] and a planned comparison indicated that
the shift/stroke had smaller volumes when compared to the other
groups (p = 0.001). (D) A natural log transformation was performed as
Levene’s test was violated and a One-Way ANOVA revealed that the
average area per section of FJ signal differed between the groups
[F(3, 22) = 8.918, p < 0.001]. A planned comparison indicated that the
shift/stroke group had a greater area of damaged neurons when
compared to the other groups (p = 0.001).
impairments (Amtul et al., 2014a,b; Deibel et al., unpublished).
Finally, factor combinations can have no effect on hippocampal
pathology or behavior (Craig et al., 2009b). As a whole our
data support the notion that AD pathogenesis is heterogeneous
because hippocampal pathology/behavior depends on the specific
combination of factors used.
Other labs obtained similar results with some of the risk
factor combinations we have used: Aβ+ stroke (Tong et al.,
2005; Whitehead et al., 2005a,b; Iwasaki et al., 2006; Whitehead
et al., 2007); Aβ+ chronic hypoperfusion (Choi et al., 2011);
cholinergic depletions + seizures (Jouvenceau et al., 1997;
Silveira et al., 2000); Aβ1−40 dorsal hippocampal injections +
stress (Huang et al., 2010); transgenicmice overexpressing APP+
cholinergic depletions (Gil-Bea et al., 2012; Ramos-Rodriguez
et al., 2013).
Other risk factor combinations have also been used: stroke +
diabetes (Stewart and Liolitsa, 1999); stroke + stress (Madrigal
et al., 2003); stress + seizures (Srinivasan et al., 2006); stress +
aging (Lupien et al., 1998; Sapolsky, 1999). Finally, an interesting
rat model produces all of the hallmarks of AD pathology, such as
hippocampal dependent memory impairments, amyloid plaque
deposits, hyperphosphorylated tau protein, and neurofibrillary
tangles via chronic injections of a solution consisting of Aβ1−42,
and the pro-oxidative inducing agents: ferrous sulfate and
buthionine sulfoximine (Lecanu and Papadopoulos, 2013).
Evaluation of cofactor models
The biggest strength of the cofactor model is that, unlike
transgenicmodels, it allows the etiology of SAD to be investigated
via the presentation of various risk factors. There are three
different approaches for presenting risk factors to rodents. As
mentioned above, most cofactor models present risk factors to
young adult animals. There are both positives and negatives to
this approach. Presenting risk factors to young adult animals
controls for age and thus allows a better assessment of risk
factors and how theymight interact to produce brain dysfunction
and memory impairments. However, in reality these risk factors
are occurring in an aged brain. Alternatively, risk factors can
be presented to aged animals. Data from our and other labs
suggest that pathology and cognition is exacerbated when risk
factors are presented to older animals (Driscoll et al., 2008;
Ramos-Rodriguez et al., 2013; Gidyk et al., unpublished). Finally
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risk factors can be presented to young or middle aged animals
and then the animals are allowed to age before pathology
and cognition are assessed. For example, Ramos-Rodriguez
et al. (2013) found that transgenic mice over expressing APP
were more impaired in hippocampal dependent tasks when
they were allowed to age after receiving cholinergic depletions.
We anticipate that in our model, this approach would vastly
exacerbate hippocampal pathology and behavioral impairments.
Although the last two approaches incorporate the aging risk
factor, as previously mentioned it is hard to evaluate the
contribution of other risk factors because aging is intermingled
with these factors. For example, the visual acuity of rodents
decreases with age (Brown, 2007), and thus could produce
behavioral impairments that are perceived to be due to other
risk factors. Thus, we believe that both young and aged animals
should be used in concert when evaluating risk factors.
As with the transgenic models, within a species, different
strains and exclusively males (will be discussed in detail below)
are often used in cofactor models. Strain differences are well
documented in learning and memory behavioral paradigms
(Tinius et al., 1989; Andrews et al., 1995; Paré, 1996; Pryce et al.,
1999; Cain et al., 2004; van der Staay et al., 2009; Thorpe et al.,
2012). This is amajor problem because across studies, it is unclear
if behavioral differences are a result of the factors used or the
strain or sex of species used. We and others feel that Long Evans
rats are an ideal subject for an ADmodel because of their superior
spatial learning abilities and the fact that their behavior and
physiology have been extremely well documented (Lecanu and
Papadopoulos, 2013).
The pathology induced by cofactors is going to vary depending
on which cofactors are used. Thus, some cofactors will likely not
elicit all of the hallmarks of AD pathology. While this could be
considered a weakness of the model, we feel that this is a strength
because SAD pathology varies greatly across people. On this
view, the actual mechanismmediating the cognitive impairments
might not be one of the classic hallmarks of AD pathology.
In other cases, the other factors might exacerbate the effects
of classic AD pathology. However, in both cases the cofactors
play a key role in hippocampal dysfunction and related memory
impairments.
Unjust Criticisms Directed at the Cofactor Model of
SAD
Although there are a variety of perceived weaknesses for cofactor
animal models of SAD, some of these criticisms might be unjust.
This section will offer some alternative interpretations for some
of these perceived weaknesses.
The most used criticism for animal models of AD is that
these models fail to induce the amount of neurodegeneration
seen in AD patients. There are a variety of reasons why we
do not view this as a fault. First, at the first sign of altered
cognition, AD pathology can take 10 or even 20 years to produce
the post-mortem pathology of AD patients (Jack et al., 2010;
Villemagne et al., 2013). In fact, neurodegeneration is not always
the best marker for identifying AD (Driscoll et al., 2009; La Joie
et al., 2013). Similarly, in rodents, lesion size does not always
correlate with severity of behavioral deficits, especially in the
motor domain (Metz et al., 2005; Alaverdashvili et al., 2008).
As demonstrated by some of our cofactor combinations, and
other studies measuring the effect of various brain insults on
behavior, it is possible to have behavioral impairments without
gross hippocampal damage (Jaspers et al., 1990; Wahl et al., 1992;
Yamaguchi et al., 1995; Craig et al., 2008a,b, 2009a,b; Keeley et al.,
2015; Deibel et al., unpublished). It is likely that altered synaptic
plasticity is responsible for the impaired cognition that occurs
early on in the progression of AD (Selkoe, 2002). It is possible that
animal models which do not produce neurodegeneration might
represent early AD pathology. Some suggest that a cure for AD
is not possible because the primary mechanism is aging and it is
going to be very difficult to replace dead or dying brain tissue (de
la Torre, 2012). Instead, prevention is likely the best and only way
to manage AD (de la Torre, 2012). Thus, the early stages of AD
should be the focus of human clinical work and animal models
for AD (Selkoe, 2002). Our theory is that cofactor models of SAD
are more representative of human SAD than transgenic models
of AD (see Table 1). As mentioned earlier, most of the transgenic
TABLE 1 | Summarization of the hallmarks of human SAD pathology and how well transgenic and cofactor models represent these pathologies.
SAD pathology Humans Transgenic models Cofactor models
Aβ ∼1–12 fold increase ∼5–12 fold increase ∼2.5 fold increase in several instances
Tau/Neurofibrillary tangles Present, but not due to mutations Can be present, but typically elicited by
mutations
Can be present without mutations depending on
the risk factors used
Neurodegeneration/Hippocampal
atrophy
∼15–20% reduction in
hippocampal volume in mild AD
Can be Similar to humans but depends on
the specific mutation and area of the
hippocampus
Decreased hippocampal volumes (see Figure 2)
or increased cell death depending on the risk
factors used
Cognitive impairments Episodic and working memory
impairments
Typically impairments in the gold standard
tasks depending on the mutations used,
but mice behavior poses a potential caveat
Rats typically display subtle impairments in more
sensitive variants of the gold standard tasks
Disease progression 10–20 years for end-game AD
pathology
Some disease progression, but aging can’t
be differentiated from other mechanisms
Some disease progression, which can be
precisely manipulated by experimenter
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AD models are more representative of extreme end game AD
pathology. By logical extension, animal models of AD without
neurodegeneration andminimal Aβ are arguablymore important
than a model with massive amounts of neurodegeneration or Aβ
because they represent early AD.
In addition to animal models being discounted because
of minimal neurodegeneration, those that produce minimal
cognitive impairments are also criticized. Contrary to this, Joseph
et al. (2001) stated that some animal models were actually limited
because the cognitive impairments were global and therefore
did not resemble those experienced by AD patients. As will
be discussed in the next section, the task must be taken into
consideration when interpreting behavior in animal models of
disease (Hånell and Marklund, 2014). Some of the tasks used to
assess memory in animal models of AD are very resistant to the
effects of damaging factors. For example, we recently observed
that Aβ paired with either stress or cholinergic depletions
elicited minor behavioral impairments during acquisition of
the MWT (Deibel et al., unpublished). Along this line, rats
can acquire and retain a spatial memory in the MWT with
massive hippocampal lesions (Moser et al., 1995), therefore, even
a minimal impairment in some of these tasks should not be
overlooked.
Strategies to Detect Incomplete Damage to the
HPC That Should Be Utilized in Animal Models of
SAD
As stated in the introduction, our theory is that many of the
wrong behavioral tasks are being used and we hypothesis that
more sensitive tasks would either detect memory impairments
that were not detected by the “gold standard” tasks, or provide
information as to which specific hippocampal sub-circuits are
affected. Based on our experience, we believe there are several
strategies to help deal with the problem of detecting heterogenous
and/or incomplete hippocampal damage in animal models of
SAD. One approach that has worked in our hands is designing
learning and memory tasks that place a higher demand on
hippocampal processing compared to standard versions of these
(McDonald et al., 2004). For example, we have developed spatial
(McDonald and White, 1995a), contextual (Frankland et al.,
1998; Antoniadis and McDonald, 1999, 2000) and configural
tasks (McDonald et al., 1997) that are highly sensitive, or not
sensitive at all to HPC damage. The methodological strategy we
used in these different experiments was to manipulate the level
of cue ambiguity or overlap. Spatial, contextual, or configural
tasks with high cue ambiguity were more sensitive to HPC
damage than versions with low cue ambiguity. For example, with
one cofactor combination, we observed normal acquisition in
the standard MWT, but impairments in both a mass training
session to a novel platform location and relearning of the original
platform location (Craig et al., 2008a). These manipulations
assess the ability of the hippocampus to rapidly form a novel
representation in a familiar context.
A second strategy for detecting partial HPC dysfunction
would be to use learning and memory tasks that likely require
multiple functions of the HPC mediated by different subcircuits.
For example, identifying whether or not a familiar object is out
of context rather than the identification of a novel object, has
been shown to be sensitive to incomplete damage to the HPC
that is isolated to one subfield: the dentate gyrus (Spanswick and
Sutherland, 2010). This task might be particularly sensitive to
partial HPC damage because it might require both the medial
and lateral EC contributions to HPC function (place and objects).
Similarly, the Guzowski group has also demonstrated that rats
given a drug that elicits neuroinflammation in the dentate
gyrus, were unimpaired in the classic hippocampal dependent
tasks, such as MWT, contextual fear conditioning, and novel
object recognition, however, they were impaired in aversive
and appetitive context discrimination tasks that are thought to
require pattern separation (Czerniawski and Guzowski, 2014;
Czerniawski et al., 2015).
Finally, a strategy used by our research group is based on the
idea that there are multiple learning and memory systems in the
mammalian brain and that they acquire and store different types
of information during a particular experience. These systems
are thought to interact either synergistically or competitively
to control behavior (White and McDonald, 2002). Learning
and memory tasks which induce competitions between learning
and memory systems are important tools for detecting partial
dysfunction of a particular system because competition reveals
weakness. For example, we developed a competition test between
stimulus-response vs. spatial representational control using a
modified version of the cue/place task (Sutherland and Rudy,
1988). Briefly, rats are trained to swim to a cued platform in
a circular pool located in the same spatial position for several
days. On every 4th day, the cued platform is removed and a
hidden platform is put in the same spatial location and the
rats are trained to swim to that spatial position to escape.
This pattern of training is repeated thrice for a total of 12
training days. On day 13, the visible platform is moved to a
different spatial position and the subjects are allowed to swim
to either the previously correct spatial position or the cued
position. Rats with damage to the dorso-lateral striatum, a neural
system thought to be important for stimulus-response learning,
preferentially swam to the previously correct spatial location.
Rats with damage to the HPC system preferentially swam to the
cued position. Interestingly, the HPC damage was only partial
and yet a powerful bias to the other learning and memory system
was produced (McDonald and White, 1994).
An example of the utility of this type of competition task for
applied approaches has also been demonstrated in several studies
from our lab. Using an animal model of moderate exposure to
alcohol during prenatal development, researchers showed that
neurobiological mechanisms implicated in plasticity underlying
learning and memory functions in HPC were compromised but
no learning and memory impairments were revealed using the
standard, hidden platform version of the water task. However,
using the cue/place competition task, a HPC deficit was detected
in the adult rats pre-exposed to low levels of alcohol during
prenatal development. A similar HPC impairment was revealed
using a one-trial place learning task that places a high demand
on HPC circuitry because the subjects must learn new spatial
positions in the pool each day to find the escape platform
(Sutherland et al., 2000). This pattern of behavioral effects was
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found, in our view, because the low level exposure to alcohol
during prenatal development induced partial HPC dysfunction
and was only detected using more sensitive learning andmemory
tasks.
As a whole, the data presented in this section demonstrate that
the behavior of animals with various brain pathologies can differ
even when similar tasks are used that are thought to assess the
same neural systems. These data sets also indicate tasks thought
to rely on HPC circuitry vary on their level of sensitivity to
complete vs. partial damage.
Wait a Minute: Many Current Rodent Models of AD
Demonstrate Severe Learning and Memory Deficits
We suspect that most researchers involved in developing and
utilizing rodent models of AD would not recognize the issue
concerning rodent models of SAD producing partial HPC
damage and the need for sophisticated strategies for detecting
this type of dysfunction as a significant problem. The reasons for
this are obvious. As previously described, most rodent models of
AD are for the familial version and these models have tended
to produce severe functional deficits. However, we feel that as
the field progresses the models will more accurately reflect the
conditions found in SAD patients and deficits will not be so
global.
The Use of Episodic Memory Tasks in Animal Models
of AD
In addition to the use of variants of the “gold standard”
tasks, some suggest that other behavioral tasks might be more
representative of the type of memory affected in human AD
patients. For example, many drugs that improve memory or
cognition in preclinical testing are often not successful in human
clinical trials (Kimmelman and London, 2011; Crystal and
Glanzman, 2013). Some argue that the wrong behavioral tasks are
used (Joseph et al., 2001; Crystal, 2013; Crystal and Glanzman,
2013). It is possible that disconnect between animal models and
human clinical trials exists because in animal models we often are
not assessing the type of memory that might be effected in human
AD patients.
As discussed in the introduction, episodic memories are
more sensitive to the effects of aging and dementia related
diseases than semantic memories (Hodges and Patterson, 1995;
Perry et al., 2000; for review see Tulving and Markowitsch,
1998). Although spatial learning is hippocampal dependent
(Morris et al., 1982; Sutherland et al., 1983), there are crucial
differences between spatial and episodic memory. Primarily,
some argue that after extensive training, spatial learning tasks can
involve semantic memory (Crystal, 2013). Furthermore, spatial
tasks involve allocentric spatial representations, whereas episodic
memory tasks often involve egocentric representations (Davis
et al., 2013a,b). Aging/brain pathology can differentially affect the
processes mediating allocentric and egocentric representations
(Davis et al., 2013a,b; Serino et al., 2014). Along these lines, it
would interesting to assess path integration in animal models of
AD. As path integration does not involve the use of allocentric
cues it is possible that the AD like animals might be differentially
impaired in path integration tasks compared to other spatial
navigation tasks.
Although there is much debate about whether animals are
capable of episodic memory, there are episodic like rodent
memory tasks, which involve the discrimination of an event at
a certain time or place (for reviews see, Crystal, 2013; Easton and
Eacott, 2013). These tasks primarily differ from spatial learning
tasks in that they have a temporal component and often involve
less training than spatial learning tasks. Eacott and colleagues
have used an episodic like memory task to evaluate behavioral
impairments in a transgenic AD mouse model (Davis et al.,
2013a,b). They demonstrated that normal aged and transgenic
AD mice were impaired in the episodic like what-where-which
task, but not in several other hippocampal dependent tasks: a
temporal order task and what-where-when task (Davis et al.,
2013a,b). We predict that this effect might be producible for
some cofactor combinations. In fact, along with other criteria,
this effect could be used to determine which co-factors or SAD
models truly represent the SAD phenotype.
However, it should be noted that there are alternative
explanations for disconnect between clinical studies and animal
models. For example, the most likely explanation is that animal
models artificially elevate levels of various AD pathologies and
then treatments are used that target these pathologies specifically.
However, as mentioned before, human AD pathology is so
heterogeneous and hard to diagnose while alive, that a drug that
mitigates a specific AD pathology in an animal model would
likely only be effective in a very specific subset of AD patients.
Other Factors that Need to be Considered in Future
Models
In addition to the type of animal model and task, there are
several other factors that need to be incorporated into future
models. First, to our knowledge very few studies differentiate
hippocampal pathology in the ventral and dorsal regions. As
posited by Maruszak and Thuret (2014), the dorsal HPC
(posterior HPC in humans) is required for spatial and temporal
tasks that require fine contextual information, whereas the
ventral HPC (anterior HPC in humans) is thought to be involved
in representing general contextual information that is required
for contextual discrimination (Ruediger et al., 2012). The finding
in rats that the dorsal HPC is required for the standard version
of the MWT and the ventral HPC is not, supports this notion
(Moser et al., 1995). Interestingly, as discussed by Maruszak
and Thuret (2014), in human AD patients, there is more
neurodegeneration in the ventral compared to the dorsal HPC
(Raji et al., 2009).
With this in mind, we predict that animal models of AD
should have more severe pathology in the ventral hippocampus
and be more impaired on tasks that specifically assess ventral
hippocampal function. Surprisingly, some transgenicmodels find
more pathology in the dorsal HPC (Rodríguez et al., 2008; Fuster-
Matanzo et al., 2011). In contrast to the transgenic models, some
of our recent cofactor combinations in rats appear to mirror the
human pathology, by suggesting that the ventral HPC is more
susceptible to risk factors. For example, just as in mice with
ventral HPC lesions (Ruediger et al., 2012), we recently have
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observed that several passive factor combinations (stress + Aβ;
cholinergic depletions + Aβ) only produced impairments early
on in MWT acquisition (Deibel et al., unpublished). These data
fit with the finding that the ventral HPC is more susceptible
to the malaffects of mild chronic stress (Jayatissa et al., 2008)
and chronic alcohol consumption (Lescaudron and Verna, 1985).
In summary, more animal models of AD need to quantify
hippocampal pathology in the dorsal and ventral regions, as
these regions have different functions and in humans can be
differentially affected during AD. Similar to performance in
episodic memory tasks, this analysis might help undercover
animal models that are more representative of human AD
pathology.
Another, largely ignored shortcoming of most animal models
of AD are sex differences. Exhaustive animal and human data
indicate that there are sex differences in cognition, particularly
spatial learning (for review see, Li and Singh, 2014). Not
surprisingly, there is also a sex difference in AD, with women
more likely to develop AD and in some cases have more severe
pathology/cognitive impairments (Zhang et al., 1990; Proust-
Lima et al., 2008; Viña and Lloret, 2010; for review see, Li
and Singh, 2014). While some transgenic models of AD have
manipulated sex hormones and assessed cognition/pathology,
very few studies have looked at sex differences in their AD model
(for review see, Li and Singh, 2014). We predict that it is very
likely that males and females in animal models of AD would
be differentially affected by the various manipulations used to
induce AD pathology. For example, female ApoE4 knockin mice
were more impaired in spatial learning tasks and had more
severe hippocampal pathology (hilar GABAergic interneurons)
than their male counterparts (Leung et al., 2012). It would be
interesting to determine if some manipulations used to induce
AD are more prone to sex differences than others. Similar to
the argument for using episodic memory task and quantifying
pathology in the dorsal and ventral hippocampal regions, it is
likely that the evaluation of sex differences in animal models
of AD would help identify those models that are more akin to
human AD.
Conclusions
Understanding the etiology of the sporadic version of AD,
let alone developing cogent strategies for preventing and/or
treating this brutal neurodenerative disorder represents an
extremely difficult and complex task. In the present paper,
we presented just a few of the barriers to the development
of a valid rodent model of SAD. These barriers include the
use of mutant mouse models of the familial version of this
disorder that do not represent the disease state in humans
with this rare aﬄiction let alone the masses of aged patients
with SAD. A second barrier is that the behavioral tasks
predominantly used do not detect partial and heterogenous
damage to the hippocampal system. As rodent models of SAD
improve, we believe that partial hippocampal dysfunction will
be a hallmark, which is consistent with the human clinical
literature. Similarly, other characteristics of human SAD, such
as sex differences, and mechanism heterogeneity should be
considered when developing rodent models of SAD. However,
this means that animal researchers will need the behavioral tools
for detecting this incomplete damage that will often manifest
itself heterogeneously across a large cohort of subjects. If progress
on these issues can be made, the ability to accurately model
SAD in rodents will be possible and this will allow a better
evaluation of neuroprotection and rehabilitation strategies at
different developmental time-points for this neurodegenerative
disease.
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